Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting

/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of an abstract in amyotrophic lateral sclerosis (ALS) at the...

Related Keywords

Jersey ,Brazil ,Osaka ,Japan ,Switzerland ,South Korea ,Tanabe Pharma America ,Gustavoa Suarez Zambrano ,Mitsubishi Tanabe Pharma America Inc ,Mitsubishi ,Drug Administration ,Outcomes Research ,Mitsubishi Tanabe Pharma Corporation ,Twitter ,Mitsubishi Chemical Group ,Linkedin ,Society For Health Economics ,Tanabe Pharma America Inc ,Facebook ,Professional Society ,Health Economics ,Vice President ,Medical Affairs ,Gdata Mart ,Preliminary Analysis ,Edaravone Treated Patients ,Amyotrophic Lateral Sclerosis Enrolled ,Based Administrative Claims ,Polina Da Silva ,Orphan Drug Exclusivity ,Mitsubishi Tanabe Pharma America ,Oral Suspension ,Prescribing Information ,Jersey City ,Tanabe Pharma Corporation ,Tanabe Pharma ,Health Care Amp Hospitals ,Pharmaceuticals ,Medical Pharmaceuticals ,